Case Study: a global pharmaceutical leader achieves early rare disease detection with Tiger Analytics

a global pharmaceutical leader achieves 72% accurate early rare disease detection with Tiger Analytics

The client, a global pharmaceutical leader, faced the challenge of rare diseases being frequently misdiagnosed or diagnosed late due to limited awareness and treatment options, which led to avoidable health decline. They partnered with Tiger Analytics to develop a solution for the early detection of these patients to address medical gaps and enhance patient well-being.

Tiger Analytics implemented an AI/ML solution that utilized cohort creation and predictive modeling. This approach successfully identified rare disease patients early, achieving 72% accurate early identification and surpassing clinical methods. The solution from Tiger Analytics notably identified 1% of new undiagnosed patients with a high likelihood of a rare disease, connecting them to suitable healthcare providers and delivering impactful value.